Course and risk factors for excessive daytime sleepiness in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 24, Issue , 2016, Pages 34-40

  Zhu, Kangdi ^a   van Hilten, Jacobus J ^a   Marinus, Johan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Excessive daytime sleepiness; Parkinson's disease; Risk factors

Indexed keywords

BENZODIAZEPINE;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; COGNITIVE DEFECT; DAYTIME SOMNOLENCE; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; DYSKINESIA; EXCESSIVE DAYTIME SLEEPINESS; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; AGED; COMPLICATION; CROSS-SECTIONAL STUDY; DISABILITY; DISORDERS OF EXCESSIVE SOMNOLENCE; LONGITUDINAL STUDY; MIDDLE AGED; NONPARAMETRIC TEST; QUESTIONNAIRE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

AGED; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVEYS AND QUESTIONNAIRES; SURVIVAL ANALYSIS;

EID: 84958966271     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2016.01.020     Document Type: Article

References (30)

1. Hobson D.E., Lang A.E., Martin W.R., Razmy A., Rivest J., Fleming J. Excessive daytime sleepiness and sudden onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002, 287:455-463.
2. International Classification of Sleep Disorders 2014, American Academy of Sleep Medicine, Darien, IL. third ed.
3. Weerkamp N.J., Tissingh G., Poels P.J., Zuidema S.U., Munneke M., Koopmans R.T., Bloem B.R. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life. J. Am. Geriatr. Soc. 2013, 61:1714-1721.
4. Tholfsen L.K., Larsen J.P., Schulz J., Tysnes O.B., Gjerstad M.D. Development of excessive daytime sleepiness in early Parkinson disease. Neurology 2015, 85:162-168.
5. Gjerstad M.D., Aarsland D., Larsen J.P. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002, 58:1544-1546.
6. Thorpy M., Billiard M. Sleepiness: Causes, Consequences and Treatment 2011, 388-392. Cambridge University Press, Cambridge.
7. Dahlöf C., Dimenäs E. Side effects of beta-blocker treatments as related to the central nervous system. Am. J. Med. Sci. 1990, 299:236-244.
8. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1988, 51:745-752.
9. Verbaan D., Marinus J., Visser M., van Rooden S.M., Stiggelbout A.M., Middelkoop H.A., van Hilten J.J. Cognitive impairment in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:1182-1187.
10. Esselink R.A., de Bie R.M., de Haan R.J., Lenders M.W., Nijssen P.C., Staal M.J., Smeding H.M., Schuurman P.R., Bosch D.A., Speelman J.D. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004, 62:201-207.
11. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality 1967. Neurology 2001, 57:S11-S26.
12. Marinus J., Visser M., Stiggelbout A.M., Rabey J.M., Martínez-Martín P., Bonuccelli U., Kraus P.H., van Hilten J.J. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J. Neurol. Neurosurg. Psychiatr. 2004, 75:388-396.
13. Visser M., Verbaan D., van Rooden S.M., Stiggelbout A.M., Marinus J., van Hilten J.J. Assessment of psychiatric complications in Parkinson's disease: the SCOPA-PC. Mov. Disord. 2007, 22:2221-2228.
14. Visser M., Marinus J., Stiggelbout A.M., van Hilten J.J. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov. Disord. 2004, 19:1306-1312.
15. Marinus J., Visser M., van Hilten J.J., Lammers G.J., Stiggelbout A.M. Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003, 26:1049-1054.
16. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:53-63.
17. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbe L., Huber S., Koller W., Olanow C., Shoulson I., et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990, 40:1529-1534. The Parkinson Study Group.
18. Videnovic A., Golombek D. Circadian and sleep disorders in Parkinson's disease. Exp. Neurol. 2013, 243:45-56.
19. van der Heeden J.F., Marinus J., Martinez-Martin P., van Hilten J.J. Importance of nondopaminergic features in evaluating disease severity of Parkinson disease. Neurology 2014, 82:412-418.
20. van Rooden S.M., Visser M., Verbaan D., Marinus J., van Hilten J.J. Patterns of motor and non-motor features in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2009, 80:846-850.
21. Schulz-Schaeffer W.J. The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol. 2010, 120:131-143.
22. Shpirer I., Miniovitz A., Klein C., Goldstein R., Prokhorov T., Theitler J., Pollak L., Rabey J.M. Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study. Mov. Disord. 2006, 21:1432-1438.
23. Arnulf I., Konofal E., Merino-Andreu M., Houeto J.L., Mesnage V., Welter M.L., Lacomblez L., Golmard J.L., Derenne J.P., Agid Y. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002, 58:1019-1024.
24. Baldwin C.M., Kapur V.K., Holberg C.J., Rosen C., Nieto F.J. Sleep Heart Health Study Group, Associations between gender and measures of daytime somnolence in the Sleep Heart Health Study. Sleep 2004, 27:305-311.
25. Simuni T., Caspell-Garcia C., Coffey C., Chahine L.M., Lasch S., Oertel W.H., Mayer G., Högl B., Postuma R., Videnovic A., Amara A.W., Marek K. PPMI Sleep Working group on behalf of the PPMI Investigators. Correlates of Excessive Daytime Sleepiness in De Novo Parkinson's Disease: A Case Control Study. Mov. Disord. 2015, 30, 1371-1381, 10.1002/mds.26248.
26. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
27. Kingsbury A.E., Bandopadhyay R., Silveira-Moriyama L., Ayling H., Kallis C., Sterlacci W., Maeir H., Poewe W., Lees A.J. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model. Mov. Disord. 2010, 25:2508-2515.
28. Suchowersky O., Furtado S., Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease. Mov. Disord. 1995, 10:337-340.
29. Jiménez-Urbieta H., Gago B., de la Riva P., Delgado-Alvarado M., Marin C., Rodriguez-Oroz M.C. Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches. Neurosci. Biobehav Rev. 2015, 26:S0149-S7634.
30. Kotschet K., Johnson W., McGregor S., Kettlewell J., Kyoong A., O'Driscoll D.M., Turton A.R., Griffiths R.I., Horne M.K. Daytime sleep in Parkinson's disease measured by episodes of immobility. Park. Relat. Disord. 2014, 20:578-583.